FR2814367B1 - NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA - Google Patents
NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIAInfo
- Publication number
- FR2814367B1 FR2814367B1 FR0012164A FR0012164A FR2814367B1 FR 2814367 B1 FR2814367 B1 FR 2814367B1 FR 0012164 A FR0012164 A FR 0012164A FR 0012164 A FR0012164 A FR 0012164A FR 2814367 B1 FR2814367 B1 FR 2814367B1
- Authority
- FR
- France
- Prior art keywords
- hyperalgia
- pain
- treatment
- receptor ligands
- npff receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0012164A FR2814367B1 (en) | 2000-09-25 | 2000-09-25 | NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA |
AU2001291994A AU2001291994A1 (en) | 2000-09-25 | 2001-09-25 | Dipeptide ligands of the npff receptor for treating pain and hyperalgesia |
PCT/FR2001/002973 WO2002024192A1 (en) | 2000-09-25 | 2001-09-25 | Dipeptide ligands of the npff receptor for treating pain and hyperalgesia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0012164A FR2814367B1 (en) | 2000-09-25 | 2000-09-25 | NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2814367A1 FR2814367A1 (en) | 2002-03-29 |
FR2814367B1 true FR2814367B1 (en) | 2008-12-26 |
Family
ID=8854636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0012164A Expired - Fee Related FR2814367B1 (en) | 2000-09-25 | 2000-09-25 | NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001291994A1 (en) |
FR (1) | FR2814367B1 (en) |
WO (1) | WO2002024192A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7276249B2 (en) | 2002-05-24 | 2007-10-02 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
JPWO2004080965A1 (en) * | 2003-03-14 | 2006-06-08 | 協和醗酵工業株式会社 | Neuropeptide FF receptor antagonist |
CL2004000553A1 (en) * | 2003-03-20 | 2005-02-04 | Actelion Pharmaceuticals Ltd | USE OF GUANIDINE DERIVATIVE COMPOUNDS AS ANTAGONISTS OF THE FF NEUROPEPTIDE RECEIVER; COMPOUNDS DERIVED FROM GUANIDINA; PREPARATION PROCEDURES; AND PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM. |
FI20031454A0 (en) | 2003-10-06 | 2003-10-06 | Juvantia Pharma Ltd Oy | Selective somatostatin receptor 1 and / or 4 agonists and antagonists |
EP2669276A1 (en) | 2012-05-31 | 2013-12-04 | Université de Strasbourg | Ornithine- and lysine-derivatives for the treatment of pain |
US11014964B2 (en) * | 2017-07-21 | 2021-05-25 | Sichuan Haisco Pharmaceutical Co., Ltd. | Peptide amide compound and preparation method and medical use thereof |
CA3086668A1 (en) | 2018-02-05 | 2019-08-08 | Universite De Strasbourg | Compounds and compositions for the treatment of pain |
WO2021023813A1 (en) | 2019-08-06 | 2021-02-11 | Domain Therapeutics | 5-heteroaryl-pyridin-2-amine confounds as neuropeptide ff receptor antagonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4326465A1 (en) * | 1993-01-20 | 1995-02-09 | Thomae Gmbh Dr K | Amino acid derivatives, pharmaceutical compositions containing these compounds and process for their preparation |
GB9500601D0 (en) * | 1995-01-12 | 1995-03-01 | Wellcome Found | Modified peptides |
DE19544686A1 (en) * | 1995-11-30 | 1997-06-05 | Thomae Gmbh Dr K | Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
US6262246B1 (en) * | 1998-09-25 | 2001-07-17 | Synaptic Pharmaceutical Corporation | DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
-
2000
- 2000-09-25 FR FR0012164A patent/FR2814367B1/en not_active Expired - Fee Related
-
2001
- 2001-09-25 AU AU2001291994A patent/AU2001291994A1/en not_active Abandoned
- 2001-09-25 WO PCT/FR2001/002973 patent/WO2002024192A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
FR2814367A1 (en) | 2002-03-29 |
WO2002024192A1 (en) | 2002-03-28 |
AU2001291994A1 (en) | 2002-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26852A1 (en) | SELECTIVE AGONISTS OF THE EP4 RECEPTOR FOR THE TREATMENT OF OSTEOPOROSIS | |
FR13C0060I2 (en) | FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYLUREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS | |
DE60112340D1 (en) | Absorbent mat for the treatment of excreta | |
DE60035378D1 (en) | Device for the treatment of intervertebral discs | |
DE60114808D1 (en) | SURFACE TREATMENT OF MEDICAL DEVICE | |
FR05C0033I2 (en) | R-ENANTIOMER OF N-PROPARGYL-1-AMINO-INDANE FOR THE TREATMENT OF VARIOUS DISEASES AND ITS MESYLATE, ESYLATE AND SULFATE | |
DE69825447D1 (en) | DERMATOLOGICAL TREATMENT DEVICE | |
DZ3442A1 (en) | COMBINATION OF FENOFIBRATE AND COENZYME Q10 FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION | |
NO20042208L (en) | Vaginally administered anti-dysrhythmic agents for the treatment of pelvic pain | |
FR2816513B1 (en) | SUBCUTANEOUS VALVE FOR THE TREATMENT OF HYDROCEPHALIA AND ITS ADJUSTMENT DEVICES | |
FR2775078B1 (en) | METHOD AND DEVICE FOR THE TREATMENT OF DISHWASHER IN DISHWASHER | |
DZ3209A1 (en) | Selective iGLuR5 receptor antagonists used in the treatment of migraine. | |
FR2815541B1 (en) | USE OF PERICYTE APOPTOSIS INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC RETINOPATHY | |
DE60101354D1 (en) | Emulsions containing diorganopolysiloxane / acrylate copolymer for the treatment of fabrics | |
DE60136477D1 (en) | RETINOIDES FOR THE TREATMENT OF EMPHYSEM | |
DE60037240D1 (en) | VIBRATION MASSAGE DEVICE FOR PAIN TREATMENT | |
FR2778330B1 (en) | APPARATUS FOR ORTHODONTIC TREATMENT | |
FR2818917B1 (en) | FILTER FOR THE PARTICULATE DEPOLLUTION OF FLUIDS | |
FR2814367B1 (en) | NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA | |
DE60016047D1 (en) | DIHYDROBENZOPYRANE, DIHYDROBENZOTHIOPYRANE AND TETRAHYDROCHINOLINE FOR THE TREATMENT OF COX-2-DEPENDENT DISEASES | |
DE60127712D1 (en) | SELECTIVE DOPAMINE D4 RECEPTOR AGONISTS FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS | |
MA25852A1 (en) | METHOD FOR THE TREATMENT OF INFLAMMATION. | |
FR2800614B1 (en) | COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS | |
FR2786096B1 (en) | COMPOSITION FOR THE PREVENTION AND TOPICAL TREATMENT OF CELLULITE | |
PT1073431E (en) | APPLICATION OF NMDA ANTAGONISTS IN THE TREATMENT OF IRRITAVEL INTESTINE SYNDROME |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TQ | Partial transmission of property | ||
TQ | Partial transmission of property | ||
ST | Notification of lapse |
Effective date: 20120531 |